- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03286270
A mRUS Validation Study for Nail-treated Fractures of Long Bones and a TUS Exploratory Study for Nail and Plate-treated Fractures of Long Bones (mRUSTUS)
Early intervention attempts to shorten protracted delayed union (DU) or prevent non-union (NU) fractures are hampered by lack of validated quantitative assessment tools for bone fracture healing during normal and delayed healing processes. In actual practice, sequential X-rays usually follow a pre-determined time interval in patients with fractures.They constitute the best available state of the art used by surgeons to assess the fracture healing course.
In an attempt to improve between raters reliability of radiographic assessment of healing, studies have explored a novel radiographic assessment for tibial shaft fractures, the Radiographic Union Scale for Tibial Fractures (RUST). The RUST assesses the presence of bridging callus and a fracture line on each of four cortices (seen on anterior-posterior and lateral views). This callus based scoring system has been since extended to other bones than the tibia in a retrospective case series. It has been renamed modified radiological union score (mRUS) and has shown potential value in bone healing measurement.
Based on an initial retrospective study in nail-treated fractures, the first objective of the present investigation is to prospectively validate mRUS as a tool to identify patients at increased risk of DU and NU within the first 75-110 days after fracture occurrence. This prospective validation will be performed on a retrospective cohort of patients having sustained long bone fractures, including both upper and lower extremities. A further objective of the present investigation is to apply the scoring system to tomographic imaging in case of nail/plate treated fractures, deriving a tomographic union score (TUS) and first assess its potential value in bone healing for fractures treated by nails/plates.
Study Overview
Status
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Cologne, Germany
- Investigating site DE01
-
Lübeck, Germany
- Investigating site DE03
-
Munich, Germany
- Investigating site DE02
-
Würzburg, Germany
- Investigating site DE04
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or female adult patient (>18 and < 80 years old)
- Patient with nail(s) (for mRUS validation study and TUS exploratory study) or plate(s) (for TUS exploratory study) treated long bone fractures, corresponding to the following OA/OTA classification: 11-A, 12-A, -B and -C, 13-A, 21-A, 22-A, -B and -C, , 31-A3, 32-A, -B and -C, 33-A 41-A2 and A3, 42-A, -B and -C and 43-A
- Patient for whom outcome of fracture is known
- For the mRUS validation study, patient with one follow up X-ray imaging performed 75-110 days after fracture occurrence
- For the TUS exploratory study, patient with one follow up CT-scan imaging performed 75-110 days after the fracture occurrence
Exclusion Criteria:
- Bone infection diagnosed between time of the fracture occurrence and the X-Ray or CT-scan imaging performed 75-110 days after the fracture occurrence
- Previous fracture and previous surgery on the fractured bone
- Bone tumour or history of bone tumour
- Bone metastasis
- Known evidence for ongoing metabolic bone disease (e.g. chronic renal failure, hyper or hypoparathyroidism, rickets, Paget's disease of bone, inherited or congenital bone abnormalities)
- Patient with current traumatic brain injury
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
mRUS assessed on X-Ray
Time Frame: 75-110 days after fracture occurrence
|
75-110 days after fracture occurrence
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
TUS assessed on CT-scan
Time Frame: 75-110 days after fracture occurrence
|
75-110 days after fracture occurrence
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 002A/BT
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Fracture
-
Cairo UniversityCompletedClavicle Fracture | Bone Fracture | Bone LesionEgypt
-
Corporacion Parc TauliUnknownScaphoid Bone FractureSpain
-
VieCuri Medical CentreCompletedBone FractureNetherlands
-
Sheffield Children's NHS Foundation TrustUnknown
-
IWK Health CentreCompletedSplints | Metacarpal Fracture | Bone Fractures | Boxer's FractureCanada
-
Instituto Venezolano de Investigaciones CientificasHospital Central Dr. Plácido D. Rodriguez Rivero; Instituto Autónomo Hospital...Enrolling by invitationPseudarthrosis | Non Union Fracture | Pseudoarthrosis of Bone | Nonunion Bone FractureVenezuela
-
Damanhour UniversityCompleted
-
Barts & The London NHS TrustLondon DeaneryCompletedLong Bone Fracture | Vitamin DUnited Kingdom
-
IlluminOss Medical, Inc.CompletedHumerus Pathological FractureAustria, Germany, Netherlands
-
University Medicine GreifswaldDeutsche Arthrose-HilfeCompletedFracture of Metacarpal BoneGermany